Jason Hadley, MD
Dermatology · Bountiful, UTNPI 1619148129
Payments from drug & device makers
Across 713 payments — averaging $669.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$153K
- AbbVie$151K
- Sanofi US Services Inc.$106K
- Janssen Research & Development, LLC$57K
- Amgen$4K
- Genentech USA, Inc.$2K
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 152 | $153,188 |
| AbbVie(2 entities) | 313 | $151,328 |
| Sanofi US Services Inc. | 19 | $105,818 |
| Janssen Research & Development, LLC | 6 | $56,855 |
| Amgen | 13 | $4,188 |
| Genentech USA, Inc. | 12 | $1,612 |
| Novartis | 41 | $827 |
| Dermavant Sciences, Inc. | 33 | $578 |
| UCB, Inc. | 14 | $560 |
| Pfizer | 21 | $293 |
| Sun Pharmaceutical Industries Inc. | 13 | $250 |
| Biofrontera Inc. | 8 | $165 |
| Dermira, Inc. | 3 | $161 |
| LEO Pharma Inc. | 7 | $159 |
| Lilly USA, LLC | 7 | $128 |
| Sanofi | 7 | $124 |
| VYNE Pharmaceuticals Inc. | 3 | $121 |
| Johnson & Johnson | 5 | $107 |
| Arcutis Biotherapeutics, Inc. | 6 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $85 |
| Organon | 6 | $75 |
| E.r. Squibb & Sons, L.L.C. | 4 | $74 |
| Incyte Corporation | 3 | $56 |
| Mimedx Group, Inc. | 2 | $43 |
| Mylan Pharmaceuticals Inc. | 2 | $26 |
| Strata Skin Sciences, Inc. | 2 | $23 |
| Krystal Biotech Inc | 1 | $21 |
| Boehringer Ingelheim | 1 | $19 |
| Qiagen, LLC | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Botanix SB Inc | 1 | $14 |
| Sensus Healthcare, Inc. | 1 | $6 |
How this compares
$477,057 in reported general payments places this provider in the 95th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Bountiful
- Jamie RhoadsMurray$2.5M
- Doug Lass ForshaWest Jordan$2.2M
- Michael PetersonSpanish Fork$1.6M
- Kristina DuffinSalt Lake City$1.2M
- Gerald KruegerSalt Lake City$1.1M
- Brian WilliamsMidvale$876K
- Mark TaylorSalt Lake City$473K
- Travis JamesProvidence$472K
- Douglas WosethSalt Lake$466K
- James MacdonaldLehi$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.